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ABSTRACT 
Objective: The objective of the present work is to develop and validate a new UV derivative spectrophotometric method for simultaneous 
estimation of metoprolol succinate and ramipril in methanol: water (50:50v/v). 
Methods: “Zero crossing technique” was chosen for quantitative determination. The zero-crossing points (ZCP’s) were found to be 209 nm where 
metoprolol succinate was quantified and 211 nm where ramipril was quantified. This method was then subjected to accuracy, linearity, sensitivity 
and reproducibility according to ICH guidelines to ensure and confirm its validity. 
Results: The method was found to be obeying Beer’s law in the range of 10-50 µg/ml and 5-25 µg/ml for metoprolol succinate and ramipril, 
respectively. The % recoveries were observed between the range of 99.2-100.2 for metoprolol succinate and 99.57-99.86 for ramipril. The intra-day 
and inter-day results showed reproducibility. 
Conclusion: It can be concluded that the developed third-order UV derivative spectroscopic method for the simultaneous determination of 
metoprolol succinate and ramiprilcan be recommended for routine quantitative analysis. 
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INTRODUCTION 
Metoprolol succinate is chemically known as 1-[4-(2-methoxyethyl) 
phenoxy]-3-(propan-2-ylamino) propan-2-olbutanedioate (fig. 1). It 
competes with adrenergic neurotransmitters such as catecholamines 
for binding at β1-adrenergic receptors in the heart that result in a 
decrease in heart rate, blood pressure and cardiac output [1, 2]. 
Ramipril as shown in (fig. 2) is chemically (2S,3aS,6aS)-1-[(2S)-2-
[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino] propanoyl]-
3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid, 
acts by inhibiting angiotensin-converting enzyme (ACE), thereby 
lowers the production of angiotensin II and also decreases the 
breakdown of bradykinin. The decrease in angiotensin II results in 
lowering total peripheral resistance, widening the blood vessels and 
hence decreases the blood pressure [3]. Commercial brands of 
metoprolol succinate and ramipril are available and have been 
prescribed to the patients who are suffering from myocardial 
infarction, nephropathy, angina and congestive heart failure [4].  
Literature survey revealed that metoprolol succinate and ramipril can be 
estimated either individually or combinedly by different methods like 
HPLC [5-7], LC [8], RP-UPLC [9], UV-Spectroscopy [10, 11]. However, 
simultaneous estimation of these drugs by derivative spectro-
photometric method was not reported till date. Hence a third order 
derivative spectrophotometric method was developed for the 
simultaneous estimation of these drugs for the first time. The developed 
UV derivative method was validated according to the ICH guidelines. 
 
 
Fig.1: Structure of metoprolol succinate 
 
Fig. 2: Structure of ramipril 
 
MATERIALS AND METHODS 
Instrument 
A double beam Agilent Cary UV spectrophotometer with Cary WinUV 
software (version 5.0.0.999) having a wavelength range of 190-1100 
nm and 1 cm quartz cell was used for all the spectral studies. A 
calibrated Shimadzu BL 220H weighing balance was used for 
accurate weighing of the chemicals. The statistical calculations were 
done by using Microsoft excel 2010 version. 
Chemicals and reagents 
Analytically pure metoprolol succinate and ramipril from Yarrow 
chemicals, Mumbai were used. PROLOMET R 50 tablets (in the dose 
of 50 mg metoprolol succinate and 5 mg ramipril) manufactured by 
Sun Pharma were procured and used for the investigation. 
Preparation of metoprolol succinate standard stock solution 
25 mg of metoprolol succinate was accurately weighed and 
transferred into a 25 ml volumetric flask and made up with 
methanol and water in the ratio of 50:50 v/v to get 1000 µg/ml 
solution. From the above stock solution different working standards 
in the range of 10-50 µg/ml were prepared. 
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Preparation of ramipril standard stock solution 
25 mg of ramipril was accurately weighed and transferred into a 25 ml 
volumetric flask and made up with methanol and water in the ratio of 
50:50 v/v to get 1000 µg/ml solution. From the above stock solution 
different working standards in the range of 5-25 µg/ml were prepared. 
Method development 
For quantitative estimation, UV derivative spectroscopic method 
using zero crossing technique was chosen [12]. The working 
standard solutions containing 30 μg/ml of metoprolol succinate and 
15 µg/ml of ramipril were scanned in the wavelength range of 200-
400 nm using methanol and water solvent (50:50 v/v) as reference 
in derivative mode at bandwidth of 2 nm and a scan speed of 400 
nm/min. It showed wavelength maxima at 215 nm for metoprolol 
succinate (fig. 3) and 210 nm for ramipril (fig. 4). The isobestic point 
was found to be 216 nm as shown in (fig. 5). The obtained zero order 
spectra were converted to first order (fig. 6), second order (fig. 7) 
and third order spectrum (fig. 8). 
Method validation 
The developed method was validated in terms of linearity, accuracy, 
intra-day and inter-day precision studies, detection limit and 
quantification limit according to ICH guidelines [13, 14]. 
 
 
Fig. 3: λmax of metoprolol succinate 
 
 
Fig. 4: λmax of ramipril 
 
 
Fig. 5: Zero order spectrum of metoprolol succinate and ramipril 
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Fig. 6: First order spectrum of metoprolol succinate and ramipril 
 
 
Fig. 7: Second order spectrum of metoprolol succinate and ramipril 
 
 
Fig. 8: Third order spectrum of metoprolol succinate and ramipril 
 
Linearity 
For the third order derivative method, 10-50 μg/ml of metoprolol 
succinate and 5-25 μg/ml of ramipril were scanned at the working 
wavelengths of 209 nm and 211 nm for metoprolol succinate and 
ramipril respectively. Calibration curves were constructed by 
plotting concentration against the absorbance values and correlation 
coefficients were calculated from the regression line equations. 
Accuracy 
To check the accuracy of the developed method, recovery studies 
were carried out by applying standard addition method. A known 
amount of standard metoprolol succinate and ramipril 
corresponding to 80, 100 and 120% of the label claim was added to 
pre-analyzed sample of the tablet. The recovery studies were carried 
out at each level three times and the average amount was calculated. 
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Precision 
The precision of the developed method was carried out by intermediate 
precision. The intraday and interday precisions of the third order 
derivative method were determined by analyzing responses in triplicate 
on the same day and on 3 different days over a period of 1 w of 
metoprolol succinate (50 µg/ml) and ramipril (5 µg/ml). 
Sensitivity 
The LOD and LOQ values were calculated from the linearity data using 
Microsoft excel 542010 version. Standard deviation of the analytical 
response and the slope of the calibration curve method was followed 
according to the equations, LOD = 3.3σ/S and LOQ = 10σ/S, where σ is 
the standard deviation of the sample and S is the slope.  
Assay of commercial brand 
Twenty tablets of PROLOMET R 50 were taken, weighed and finely 
powdered. The weight equivalent to the labelled claim (55 mg) was 
taken, 20 ml of solvent (methanol and water 50:50v/v) was added in 
a 100 ml volumetric flask and sonicated in an ultrasonic bath for 15 
min. This solution was then made upto 100 ml using the same 
solvent, filtered through a 0.45 μm filter and this filtrate was used to 
prepare sample solution (55 µg/ml). The mixture solution was 
scanned at the wavelengths of metoprolol succinate (209 nm) and 
ramipril (211 nm) using a UV-Visible spectrophotometer. These 
absorbance values were then substituted in the regression equations 
to calculate the concentration. 
RESULTS AND DISCUSSION 
Few chromatographic methods have been mentioned in the 
literature to date for the simultaneous estimation of metoprolol 
succinate and ramipril in their binary mixtures [6, 8, 15]. Also one 
spectrophotometric method, based on simultaneous equation has 
been reported for combination of metoprolol succinate, atorvastatin 
calcium and ramipril [16]. However, no spectrophotometric method 
has been reported for metoprolol succinate and ramipril in their 
fixed dose comination.  
Third order derivative method 
From the zero order overlain UV spectra of Metoprolol succinate 
(30 µg/ml) and ramipril (15 µg/ml), it was found that the spectra 
are overlapping each other, exhibiting the complexity in 
measuring these drugs by direct UV absorption method in a binary 
mixture. The UV derivative method has advantage that it removes 
the spectral interference from one of the two drugs while 
estimating the other drug at zero crossing point. The first order 
spectra did not show any zero crossing points (ZCP), while the 
second order spectra was not informative enough to carry out 
further experimentation. Hence in the present investigation, third 
order derivative spectrophotometric techniques was described. 
The third order spectrum showed zero crossing points (ZCP) at 
211 nm for metoprolol succinate and 209 nm for ramipril. Hence 
working wave lengths of 209 nm for metoprolol succinate and 211 
nm for ramipril were selected. 
  
Table 1: Linearity characters of the developed method 
Statistical parameters Metoprolol succinate at 209 nm Ramipril at 211 nm 
Linearity (n=5) 10-50 µg/ml 5-25 µg/ml 
Correlation coefficient (r2) 0.998 0.997 
Regression equationy=mx+c y = 0.021x+0.016 y = 0.063x+0.769 
Slope (m) 0.021 0.063 
Intercept (c) 0.016 0.769 
 
 
Fig. 9: Calibration curve of metoprolol succinate 
 
 
Fig. 10: Calibration curve of ramipril 
Padhy et al. 
Int J Pharm Pharm Sci, Vol 12, Issue 5, 54-59 
58 
Table 2: Accuracy of the developed method 
Spiked 
level 
Amount of sample taken 
(mg) 











Ramipril Metoprolol  
succinate 
Ramipril 
80% 10 5 8 4 17.88±0.01 8.96±0.01 99.32±0.05 99.57±0.17 
100% 10 5 20.1±0.01 9.94±0.02 100.53±0.07 99.4±0.26 
120% 12 6 21.82±0.02 10.98±0.03 99.19±0.11 99.81±0.27 
aSD: Standard deviation (n = 3) 
 
Table 3: Precision data of the developed method 
Parameter Metoprolol succinate (50 µg/ml) Ramipril (5 µg/ml) 
n=3 mean±SDa % RSDb n=3 mean±SDa % RSDb 
Intra-day 1.1152  1.1142±0.07 0.1008 1.058  1.0623±0.08 0.424 
1.1130  1.067  
1.1145  1.062  
Inter-day 1.1139  1.1139±0.09 0.02693 1.062  1.0706±0.06 0.754 
1.1142  1.078  
1.1136  1.072  
aSD: Standard deviation; b% Relative standard deviation (R. SD) = (standard deviation/mean)×100; (n = 3) 
 
Table 4: LOD and LOQ results of the developed method 
Statistical parameter Metoprolol succinate (µg/ml) Ramipril (µg/ml) 
LOD 3.18 1.56 
LOQ 9.62 4.68 
 
Table 5: Assay of commercial brand 




Labeled claim (mg) Amount recovered 
(mg) 





50 50.8 101.6% 5 4.94 98.8% 
 
Validity of the method 
The linearity was found in the range of 10-50 µg/ml and 5-25 µg/ml 
for metoprolol succinate and ramipril. The calibration curves were 
shown in (fig. 9 and fig. 10) and the correlation coefficient (r2) value 
was found to be 0.998 and 0.997, respectively. The r2values for both 
the drugs were found to be less than or equal to 1. Hence the 
developed method was found to be linear. The % recoveries were 
found to be 99.2%, 100.02% and 99.18% for metoprolol succinate 
and 99.5%, 99.4% and 99.81% for ramipril respectively. As the % 
recovery values were found to be between 98%-102%, the 
developed method can be considered to be accurate. The intraday % 
RSD was found to be 0.1008 for metoprolol succinate and 0.424 for 
ramipril. The inter-day % RSD was found to be 0.02693 for 
metoprolol succinate and 0.754 for ramipril. As the % RSD values 
were found to be 2%, the developed method can be considered to be 
precise. Detection limit was found to be 3.18 µg/ml for metoprolol 
succinate and 1.56 µg/ml for ramipril. Quantification limit was found 
to be 9.62 µg/ml for metoprolol succinate and 4.68 µg/ml for 
ramipril. The assay of the commercial brand was carried out and the 
recovery was found to 101.6% for metoprolol succinate and 98.8% 
for ramipril. The results of the validation are summarized in table 1, 
2, 3, 4 and 5. 
CONCLUSION 
A simple, precise, economical and sensitive UV derivative 
spectroscopic method was developed for the simultaneous 
estimation of metoprolol succinate and ramipril. The developed 
method was validated according to the ICH guidelines and was 
applied to the pharmaceutical dosage form. The result of the assay 
obtained was found to be within the acceptable limits. Hence, the 
developed method was said to be effective for routine analysis of 
metoprolol succinate and ramipril in tablet dosage form. 
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